1. Corporate Officers - M
2. Moch Kenneth I

Insider Trading History of Moch Kenneth I

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Moch Kenneth I since 2013. This trader's CIK number is 1070009. At the time of last reporting, Moch Kenneth I was the Director of Zynerba Pharmaceuticals, Inc.. (stock ticker symbol ZYNE). Also see all insider trading activities at Zynerba Pharmaceuticals, Inc..

Note that in the past MOCH KENNETH I also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Chimerix Inc (CMRX) by Moch Kenneth I

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	CMRX	0	$0	30,979	$714,475	25,000	$39,249
2013	CMRX	0	$0	2,500	$39,040	8,479	$0

Yearly summary of insider trading at Zynerba Pharmaceuticals, Inc. (ZYNE) by Moch Kenneth I

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	ZYNE	0	$0	115	$40	0	$0
2022	ZYNE	0	$0	40	$40	0	$0

Insider trading activities at 2 companies by Moch Kenneth I:

1. Chimerix Inc (CMRX)

2. Zynerba Pharmaceuticals, Inc. (ZYNE)

Table 1. Insider trading of Chimerix Inc (CMRX) by Moch Kenneth I

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-03-13	CMRX	Option Ex	15,000	1.57	23,550
2014-03-13	CMRX	Sale	18,979	25.00	474,475
2014-02-24	CMRX	Sale	11,072	20.00	221,440
2014-02-24	CMRX	Option Ex	9,072	1.57	14,243
2014-01-30	CMRX	Option Ex	928	1.57	1,456
2014-01-30	CMRX	Sale	928	20.00	18,560
2013-11-15	CMRX	Option Ex	8,479	.00	0
2013-11-15	CMRX	Sale	2,500	15.62	39,040

Table 2. Insider trading of Zynerba Pharmaceuticals, Inc. (ZYNE) by Moch Kenneth I

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-06-14	ZYNE	Sale	115	.35	40
2022-06-14	ZYNE	Sale	40	1.01	40

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moch Kenneth I (Director of Zynerba Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month